the trials should be starting in Feb for a few weeks
And then this product will be launched the correct way to Aus and UK markets, if the new management perform as they say they will then confidence should return to ISN as the product already has been put through its full testing and should be rolled out to large Chemest chains here and the UK. I'm confident that they will turn this stock around as the technology has been proven to give accurate monitoring of wheeze.
Go ISN I believe the marketing will have credibility this time.
This is my opinion as a shareholder.
ISN Price at posting:
7.4¢ Sentiment: Buy Disclosure: Held
